Indegene Limited (BOM:544172)

Market Cap	110.21B -23.4%
Revenue (ttm)	32.63B +18.4%
Net Income	4.39B +14.4%
EPS	18.21 +11.5%
Shares Out	n/a
PE Ratio	25.11
Forward PE	22.10
Dividend	2.00 (0.43%)
Ex-Dividend Date	Jun 13, 2025

Volume	18,856
Average Volume	42,135
Open	471.60
Previous Close	472.00
Day's Range	456.10 - 472.85
52-Week Range	455.80 - 632.10
Beta	n/a
RSI	36.71
Earnings Date	Apr 28, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Commercial Physical and Biological Research
• Founded: 1998
• Employees: 4,158
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544172

Financial Performance

In fiscal year 2025, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.